-- European Stocks Rise as U.S. Jobless Claims Fall; Xstrata Rallies on Talks
-- B y   A d a m   H a i g h
-- 2012-02-02T16:57:19Z
-- http://www.bloomberg.com/news/2012-02-02/european-u-s-futures-rise-as-asian-shares-gain-deutsche-bank-may-fall.html
European (SXXP)  stocks climbed for a third
day as a report showed that U.S. jobless claims dropped more
than economists had estimated and Glencore International Plc
held talks to buy  Xstrata Plc (XTA) , boosting mining companies.  Xstrata jumped 9.9 percent after confirming that Glencore
made an approach about an offer for the coal, copper and nickel
miner. Unilever dropped 4.4 percent as the world’s second-
largest consumer-goods maker posted revenue growth that missed
analysts’ estimates.  AstraZeneca Plc (AZN)  sank 3.4 percent after
saying 2012 will be challenging for the industry  The  Stoxx Europe 600 Index  rose 0.2 percent to 260.11 at
the close for the gauge’s highest level since Aug. 1. The
benchmark measure swung between gains and losses at least 20
times earlier today.  “You have a lot of liquidity and strong companies with
strong cash flows thinking valuations are strong right now,”
said Virginie Maisonneuve, head of global equities at Schroder
Investment Management Ltd., which oversees $284 billion. “We
could see a wave of mergers and acquisitions, but it has to be
at the right valuation. It has to be a marriage that makes
sense. The good deals will go through.”  The Stoxx 600 rose 4 percent in January for its second
consecutive month of gains. The gauge has rallied  21 percent 
from its lowest level last year as the  European Central Bank 
boosted lending to banks and U.S. economic reports exceeded
estimates.  National benchmark indexes climbed in 14 of the 18 western-
 European (SXXP)  markets today. The U.K.’s FTSE 100 Index added 0.1
percent.  France ’s CAC 40 Index gained 0.3 percent and  Germany ’s
DAX Index advanced 0.6 percent.  U.S. Jobless Benefits  In the U.S., a Labor Department report showed that
applications for  unemployment benefits  fell last week more than
economists had predicted, indicating the labor market is
improving in the world’s largest economy.  Xstrata surged 9.9 percent to 1,230.5 pence after
confirming that Glencore has held talks to buy the shares in the
company that it doesn’t already own. That would add mines from
 Africa  to  Asia  to the world’s largest listed commodity trader.
Glencore has made an all-share offer, Zug, Switzerland-based
Xstrata said today in a statement to the London Stock Exchange.
Glencore already holds a  34 percent stake  in Xstrata and the
rest of the company is valued at 21.9 billion pounds ($35
billion) based on yesterday’s closing price.  Glencore’s shares soared 6.9 percent to 461.7 pence. The
company said in a statement that there’s no certainty it will
make an offer.  Novo Nordisk, Benetton  Novo Nordisk A/S (NOVOB)  rose 4.3 percent to 709.50 kroner after
the world’s largest insulin maker posted  net income  that climbed
to 4.69 billion kroner ($830 million) from 3.95 billion kroner a
year earlier. That exceeded the 4.06-billion kroner  average
estimate  of 21 analysts surveyed by Bloomberg.  Benetton Group SpA (BEN)  surged 17 percent to 4.74 euros after
the Benetton family, the company’s largest shareholder, said it
will offer 276.6 million euros ($364 million) for the shares it
doesn’t already own in the company. Edizione Holding SpA, which
owns  67 percent of Benetton , will offer 4.60 euros a share, it
said in a statement last night on the Italian bourse.  Unilever dropped 4.4 percent to 1,994 pence as the maker of
Hellmann’s mayonnaise and Lynx deodorants said it expects
difficult economic conditions and elevated commodity costs to
persist this year.  “We cannot recollect a more challenging year as 2011,”
Chief Financial Officer Jean-Marc Huet said in a teleconference
with reporters today. “The global economy is still in poor
shape and we expect it to continue.”  AstraZeneca sank 3.4 percent to 2,984 pence after saying
2012 will be challenging for the industry. It’s guidance for
this year was “disappointing,” according to Goldman Sachs
Group Inc. analyst Keyur Parekh.  To contact the reporter on this story:
Adam Haigh in London at 
 ahaigh1@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  